Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Jia-Cong Ye"'
Autor:
Jie Yang, Qiao-Li Wang, Guan-Nan Wang, Jia-Cong Ye, Zi-Qian Li, Jing-Yun Wang, Zhao-Hui Liang, Shu-Xin Li, Cong Sun, Wen-Ting Liao, Yi-Jun Gao, Jing Wang, Yong Mao, Chunjing Yu, Guo-Kai Feng, Mu-Sheng Zeng
Publikováno v:
Cell Discovery, Vol 10, Iss 1, Pp 1-14 (2024)
Abstract KRAS mutations are highly prevalent in a wide range of lethal cancers, and these mutant forms of KRAS play a crucial role in driving cancer progression and conferring resistance to treatment. While there have been advancements in the develop
Externí odkaz:
https://doaj.org/article/6787c17bde8f4bc390e82ca6554cb9e5
Autor:
Jia-Cong Ye, Wan-Qiong Li, Mei-Ling Chen, Qian-Kun Shi, Hua Wang, Xin-Ling Li, Ying-He Li, Jie Yang, Qiao-Li Wang, Fang Hu, Yan-Feng Gao, Shu-Wen Liu, Mu-Sheng Zeng, Guo-Kai Feng
Publikováno v:
Engineering, Vol 35, Iss , Pp 226-240 (2024)
There is currently no effective targeted therapeutic strategy for the treatment of central nervous system acute lymphoblastic leukemia (CNS-ALL). Integrin α6 is considered a potential target for CNS-ALL diagnosis and therapy because of its role in p
Externí odkaz:
https://doaj.org/article/41705dcc37014351ad4197ffe4069ce3
Autor:
Yi-Tai Xiao, Chao Zhou, Jia-Cong Ye, Xiao-Chun Yang, Zhi-Jian Li, Xiao-Bin Zheng, Yan Mei, Xin-Ling Li, Wei-Guang Zhang, Wei Fan, Mu-Sheng Zeng, Jian-Jun Li, Guo-Kai Feng
Publikováno v:
ACS Omega, Vol 4, Iss 13, Pp 15560-15566 (2019)
Externí odkaz:
https://doaj.org/article/4901d65111904811beb4d6b0d1cea95d
Autor:
Yan Mei, Ying‐He Li, Xiao‐Chun Yang, Chao Zhou, Zhi‐Jian Li, Xiao‐Bin Zheng, Jia‐Cong Ye, Cheng Li, Xuan‐Hong Zhang, Jian‐Min Yuan, Hui‐Qiang Huang, Wei Fan, Wei‐Guang Zhang, Mu‐Sheng Zeng, Guo‐Kai Feng
Publikováno v:
Clinical and Translational Medicine, Vol 10, Iss 4, Pp n/a-n/a (2020)
Externí odkaz:
https://doaj.org/article/a5c6034ba06c4026957daa8416fe233e
Autor:
Mu Sheng Zeng, Jia Cong Ye, Jing Cai, Guo Kai Feng, Yan Mei, Yong Jiang, Yun Zhang, Jing Zhao, Yi Tai Xiao, Chuan Miao Xie
Publikováno v:
Molecular Imaging and Biology. 22:864-872
Magnetic resonance imaging (MRI) has a high spatial resolution for detecting hepatocellular carcinoma (HCC). Integrin α6 has emerged as a diagnostic and prognostic biomarker of HCC. Here, we developed the MR contrast agent RWY-dL-(Gd-DOTA)4 based on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ce7df8967467bc78f7eee29dad6cc6e
https://doi.org/10.1007/s11307-019-01437-z
https://doi.org/10.1007/s11307-019-01437-z
Autor:
Jia-Cong Ye, XiaoFei Zhang, Si Tang, Yan Mei, Xiao-Chun Yang, Chao Zhou, Guo-Kai Feng, Wei Guang Zhang, Xu Zhang, Wei Fan
Publikováno v:
Molecular imaging and biology. 24(3)
Purpose: Positron emission tomography (PET) imaging was not efficiently used in early diagnosis of hepatocellular carcinoma (HCC) due to lack of appropriate tracers. Sodium pump Na+/K+ ATPase subunit α1 (NKAα1) emerges to be a prognostic and diagno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d34eca1b4e15c5ded5abe47635bee87c
https://pubmed.ncbi.nlm.nih.gov/34622423
https://pubmed.ncbi.nlm.nih.gov/34622423
Autor:
Xiao Chun Yang, Xin Ling Li, Zhi Jian Li, Yi Tai Xiao, Yan Mei, Wei Fan, Chao Zhou, Jian Jun Li, Jia Cong Ye, Xiao Bin Zheng, Mu Sheng Zeng, Wei Guang Zhang, Guo Kai Feng
Publikováno v:
ACS Omega, Vol 4, Iss 13, Pp 15560-15566 (2019)
ACS Omega
ACS Omega
Colorectal cancer (CRC) is the third most common cancer and the fourth leading cause of cancer deaths worldwide. Integrin α6 is overexpressed in all stages of CRC which makes it a potential diagnostic biomarker for CRC. Previously, we identified an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4e3ad7bbb3a47e54d5d28121f37c2d1
https://doaj.org/article/4901d65111904811beb4d6b0d1cea95d
https://doaj.org/article/4901d65111904811beb4d6b0d1cea95d
Autor:
Wei Guang Zhang, Jianmin Yuan, Guo-Kai Feng, Xiao-Chun Yang, Mu Sheng Zeng, Chao Zhou, Yan Mei, Xiao Bin Zheng, Jia-Cong Ye, Wei Fan, Cheng Li, Hui-Qiang Huang, Ying-He Li, Zhi-Jian Li, Xuan-Hong Zhang
Publikováno v:
Clinical and Translational Medicine, Vol 10, Iss 4, Pp n/a-n/a (2020)
Clinical and Translational Medicine
Clinical and Translational Medicine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::101279c2b212bd4f4ee45546a2bd7a92
https://doaj.org/article/a5c6034ba06c4026957daa8416fe233e
https://doaj.org/article/a5c6034ba06c4026957daa8416fe233e
Autor:
Hui Du, Da nian Dai, Yan Li, Yan Zhu Lin, Jing Zhao, Wei Fan, Zhongping Chen, Wei Xiao, Jia Cong Ye, Er Wei Song, Yan Mei, Guo Kai Feng, Chao Nan Qian, Qian Wang, Yun Fei Xia, Shi Bing Li, Man Zhi Li, De Hai Cao, Gang Hua Tang, Shi Chu Liu, Yi Tai Xiao, Yi Ying Zhao, Zhi Jian Li, Mu Sheng Zeng, Qian Zhong, Wei Guang Zhang, Xiao Bin Zheng
Publikováno v:
Journal of Controlled Release. 281:178-188
The sodium pump Na+/K+ ATPase a1 subunit(NKA a1), an attractive cancer-related biomarker and therapeutic target, is closely related to the development and progression of several cancers including breast cancer. Currently, a NKA a1 inhibitor, UNBS1450
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::343639b9becb6aaf3db3be6210676282
https://doi.org/10.1016/j.jconrel.2018.05.019
https://doi.org/10.1016/j.jconrel.2018.05.019
Autor:
Mu Sheng Zeng, Jia Cong Ye, Yan Mei, Xin Ling Li, Fan Wang, Yi Tai Xiao, Guo Kai Feng, Wei Guang Zhang, Wei Fan, Chao Zhou
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society. 310
Integrin α6 emerges to be a diagnostic biomarker for hepatocellular carcinoma (HCC). Here, we translated our previously identified integrin α6 targeted peptide RWY into a positron emission tomography (PET) tracer 18F-RWY for the detection of HCC le
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0467868a7f2258fa5c16e5e6f6871cd
https://pubmed.ncbi.nlm.nih.gov/31400382
https://pubmed.ncbi.nlm.nih.gov/31400382